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Abstract
Background: Listeriosis is a rare disease caused by the bacterium Listeria monocytogenes, the
normal vehicle of which is food. The disease, which is largely confined to its risk groups of pregnant
women, the elderly and immunocompromised individuals, has increased in incidence in recent
years.
In Portugal, listeriosis is not a notifiable infection and available data are scarce.
The objective of this work was to collate the available information concerning listeriosis in Portugal
by compiling a retrospective study of cases recorded over a decade.
Methods: Requests for case data on clinically confirmed listeriosis, recorded over the previous
decade, were replied to by 23 hospitals and a National Institute of Health delegation.
Results: 35 cases of listeriosis were identified for the period between 1994 and 2003 inclusive, the
mortality rate being greater than 17%. According to the data collected in this study for the year
2003, the incidence of this disease in Portugal was at least 1.4 cases per million inhabitants in that
year.
Conclusion: The study demonstrates, for the first time in the widely available literature, that
despite their being no cases of listeriosis in Portugal recorded in official reports, the threat of L.
monocytogenes to public health is of a similar dimension to that in other countries.
Background
Listeria monocytogenes is an ubiquitous bacterium respon-
sible for cases and outbreaks of listeriosis in humans and
animals, normally transmitted by consumption of con-
taminated foods or feeds [1]. In recent years several out-
breaks of listeriosis have been described, associated with
the consumption of a wide variety of foods, ranging from
dairy products, to ready-to-eat deli meats [1].
Although exposure to the bacterium is common [2], liste-
riosis is rare within the general population; incidence in
Europe varies between 0.3 and 7.5 cases per million
inhabitants with a mortality rate between 20 and 30% [3].
Certain groups within the general population are particu-
larly susceptible to infection, namely immunocompro-
mised persons, (e.g. organ transplant or cancer patients),
HIV-infected individuals, pregnant women, newborn
babies and the elderly [1]. In Portugal, listeriosis is not a
notifiable infection and available data are scarce [4]. In a
recent published document [3], it is stated "... all partici-
pating countries except Portugal have at least one surveil-
lance system for listeriosis". Moreover, in a publication of
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the Portuguese National Health Services concerning
advice for the prevention of infectious diseases during
pregnancy [5], L. monocytogenes is not mentioned.
The present study aimed to contribute to the knowledge
of listeriosis in Portugal through compiling a retrospective
study of the cases identified over the period between 1994
and 2003, inclusive.
Methods
Data were obtained from requests to the Clinical Pathol-
ogy Services of 23 hospitals and the National Institute of
Health's delegation in Porto. Correspondence was
received during the period between October 2003 and
February 2004. Retrospective identification of cases of lis-
teriosis during the previous decade was requested from
each hospital. The contact person in each hospital was
requested to complete a form containing the following
information regarding each case: year of isolation, age and
sex of the patient, factors that increased risk, the tissue or
fluid origin of the isolate and the outcome of the infec-
tion. For the purposes of this study a case of listeriosis is
defined as when clinical symptoms were consistent with a
systemic infection with this organism and L. monocy-
togenes  is isolated from a normally sterile site (usually
blood or cerebrospinal fluid, or less commonly, joint,
pleural, or pericardial fluid) or from placental or foetal tis-
sue in the setting of miscarriage or stillbirth and. Approval
by an Ethics Committee was not required.
Results
At least 35 cases were identified between 1994 and 2003
(Table 1). The highest annual number of cases was
recorded for the year of 2003, this might be explained by
the fact that the hospitals were contacted in October of
that year and were obviously more vigilant in the detec-
tion and recording of this infection.
The age of the patients, reported for 20 out of the 35 cases,
varied between neonates (5 new-borns, 25%) and 85
years (6 older than 65 years, 30%), and were predomi-
nantly male (13 out of the 21 cases recorded, 62%). For 7
cases other malignancies were recorded and included; cir-
rhosis, haematological syndromes, alcoholism, chronic
renal failure, nephritic syndrome and HIV infection
(Table 1).
In the present study, even though the clinical symptoms
were not recorded for the majority of cases, isolation of L.
monocytogenes from blood (40%) and from cerebrospinal
fluid (43%) was positive. The clinical signs described were
meningitis, fever and sepsis at birth. The clinical outcome,
recorded in 16 episodes, was fatal for 6 patients. Therefore
the observed death rate must lie between 17% (6/35 – the
total number of listeriosis episodes reported) and 37,5%
(6/16 – the number of listeriosis episodes for which full
case histories are available). Patients with a favourable
clinical outcome apparently did not present any sequelae.
Discussion
According to the data collected in this study, the incidence
of listeriosis was at least 1.4 cases per million inhabitants
for the year 2003 considering the resident population of
Portugal as that given by the National Institute of Statis-
tics. This relatively low incidence must be considered with
care because it is taken from a single year and the data
gathered certainly cannot be considered exhaustive. Noti-
fication of listeriosis is not legally obligatory in Portugal.
This, along with the fact that clinical symptoms are some-
times not evident, thus making diagnosis difficult, is an
impediment to the gathering of more credible data [6-8].
Considering that not all of the country's healthcare units
were contacted in this study, the national incidence rate
presented here is, of necessity, an initial estimate.
From the recorded case data, L. monocytogenes was mainly
isolated from blood and cerebrospinal fluid. It has been
reported in a study with similar scope that, in cases where
non-perinatal infection has led to clinical manifestations,
primary bacteraemia was the most common cause (47%)
followed by meningitis (28%) [7].
As reported for other countries, the majority of the cases
were non-perinatal [7]. The case-fatality rate, similar to
that reported in studies from other countries, 36% world-
wide average for non-perinatal cases [7] and 40% for
Spain [9], reflects the severity of the infection, in particu-
lar among new-borns and immunocompromised. As in
previous studies, a predominance of the infection in
males was verified [7,8].
Conclusion
The study demonstrates, for the first time in the widely
available literature, that despite their being no cases of lis-
teriosis in Portugal recorded in official reports, the threat
of L. monocytogenes to public health is of a similar dimen-
sion to that in other countries [3,4].
It is highly likely that there will be a continued increase in
the size of certain at-risk groups, namely the elderly and
immunocompromised patients. The education of these
and other, at-risk groups and of the professionals provid-
ing care for them, is proposed as a key strategy in the
reduction of the incidence of listeriosis [10]. An example
of this need is the fact that in a survey of 312 women that
had been pregnant, only 54% changed their food habits
during pregnancy (P. Teixeira, unpublished data).BMC Infectious Diseases 2006, 6:153 http://www.biomedcentral.com/1471-2334/6/153
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†DNR, Data not recorded.
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